Identification of Biomarkers and Risk Factors for Inmune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) in CD19-directed CAR T-Cell Therapy: a Retrospective Machine Learning-based Analysis

Published in EHA 2023 Hybrid Congress, 2023

Recommended citation: M. Gómez-Llobell; M. Martínez-García; C. Serra-Smith; D. Gómez-Costas; G. Oarbeascoa; D.Carbonell; J. Anguita; A. Pérez-Corral; M. Pion; VA Pérez-Fernández; I. García- Fernández; M.Bastos; P. Fernández-Caldas; I. Gómez-Centurión; A. Alarcón; E. Catalá; D. Conde; J. Gayoso; P.Olmos; C. Martínez-Laperche; J. García-Domínguez; Y. Fernández; R. Bailén; M. Kwon; IIdentification of Biomarkers and Risk Factors for Inmune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) in CD19-directed CAR T-Cell Therapy: a Retrospective Machine Learning-based Analysis. EHA2023.